These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 14738225

  • 21. MDM2 gene amplification and expression in non-small-cell lung cancer: immunohistochemical expression of its protein is a favourable prognostic marker in patients without p53 protein accumulation.
    Higashiyama M, Doi O, Kodama K, Yokouchi H, Kasugai T, Ishiguro S, Takami K, Nakayama T, Nishisho I.
    Br J Cancer; 1997; 75(9):1302-8. PubMed ID: 9155050
    [Abstract] [Full Text] [Related]

  • 22. Evaluations of p53 immunoreactivity, nucleolar organizer regions, and proliferating cell nuclear antigen in non-small cell lung carcinoma.
    Oyama T, Osaki T, Nose N, Ichiki Y, Inoue M, Imoto H, Yoshimatsu T, Kodate M, Uramoto H, Mizoue T, Yano K, Yasumoto K.
    Anticancer Res; 2000; 20(1B):505-10. PubMed ID: 10769714
    [Abstract] [Full Text] [Related]

  • 23. Correlation between survivin expression and prognosis in non-small cell lung cancer.
    Atikcan S, Unsal E, Demirag F, Köksal D, Yilmaz A.
    Respir Med; 2006 Dec; 100(12):2220-6. PubMed ID: 16650973
    [Abstract] [Full Text] [Related]

  • 24. Redefining prognostic factors for breast cancer: YB-1 is a stronger predictor of relapse and disease-specific survival than estrogen receptor or HER-2 across all tumor subtypes.
    Habibi G, Leung S, Law JH, Gelmon K, Masoudi H, Turbin D, Pollak M, Nielsen TO, Huntsman D, Dunn SE.
    Breast Cancer Res; 2008 Dec; 10(5):R86. PubMed ID: 18925950
    [Abstract] [Full Text] [Related]

  • 25. Prognostic significance of the tumor suppressor gene maspin in non-small cell lung cancer.
    Hirai K, Koizumi K, Haraguchi S, Hirata T, Mikami I, Fukushima M, Yamagishi S, Kawashima T, Okada D, Shimizu K, Kawamoto M.
    Ann Thorac Surg; 2005 Jan; 79(1):248-53. PubMed ID: 15620951
    [Abstract] [Full Text] [Related]

  • 26. Relationship of p53 overexpression and up-regulation of proliferating cell nuclear antigen with the clinical course of non-small cell lung cancer.
    Ebina M, Steinberg SM, Mulshine JL, Linnoila RI.
    Cancer Res; 1994 May 01; 54(9):2496-503. PubMed ID: 7909277
    [Abstract] [Full Text] [Related]

  • 27. Nuclear localization and increased levels of transcription factor YB-1 in primary human breast cancers are associated with intrinsic MDR1 gene expression.
    Bargou RC, Jürchott K, Wagener C, Bergmann S, Metzner S, Bommert K, Mapara MY, Winzer KJ, Dietel M, Dörken B, Royer HD.
    Nat Med; 1997 Apr 01; 3(4):447-50. PubMed ID: 9095180
    [Abstract] [Full Text] [Related]

  • 28. Golgi Phosphoprotein-3 and Y-Box-Binding Protein-1 Are Novel Markers Correlating With Poor Prognosis in Prostate Cancer.
    Abd El-Maqsoud NM, Osman NA, Abd El-Hamid AM, Fath El-Bab TK, Galal EM.
    Clin Genitourin Cancer; 2016 Apr 01; 14(2):e143-52. PubMed ID: 26794392
    [Abstract] [Full Text] [Related]

  • 29. Prognostic significance of p53 protein and X-ray repair cross-complementing protein 1 in non-small cell lung cancer.
    Rybárová S, Hodorová I, Muri J, Mihalik J, Adamkov M, Svajdler M, Piovarci D, Mirossay L.
    Tumori; 2011 Apr 01; 97(1):79-85. PubMed ID: 21528669
    [Abstract] [Full Text] [Related]

  • 30. Prognostic significance of p53 and ras p21 expression in nonsmall cell lung cancer.
    Fujino M, Dosaka-Akita H, Harada M, Hiroumi H, Kinoshita I, Akie K, Kawakami Y.
    Cancer; 1995 Dec 15; 76(12):2457-63. PubMed ID: 8625071
    [Abstract] [Full Text] [Related]

  • 31. Nuclear Y-Box-binding Protein-1 Expression Predicts Poor Clinical Outcome in Stage III Colorectal Cancer.
    Shiraiwa S, Kinugasa T, Kawahara A, Mizobe T, Ohchi T, Yuge K, Fujino S, Katagiri M, Shimomura S, Tajiri K, Sudo T, Kage M, Kuwano M, Akagi Y.
    Anticancer Res; 2016 Jul 15; 36(7):3781-8. PubMed ID: 27354655
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Predictive value of expression of p16INK4A, retinoblastoma and p53 proteins for the prognosis of non-small-cell lung cancers.
    Hommura F, Dosaka-Akita H, Kinoshita I, Mishina T, Hiroumi H, Ogura S, Katoh H, Kawakami Y.
    Br J Cancer; 1999 Oct 15; 81(4):696-701. PubMed ID: 10574258
    [Abstract] [Full Text] [Related]

  • 35. YB-1 as a cell cycle-regulated transcription factor facilitating cyclin A and cyclin B1 gene expression.
    Jurchott K, Bergmann S, Stein U, Walther W, Janz M, Manni I, Piaggio G, Fietze E, Dietel M, Royer HD.
    J Biol Chem; 2003 Jul 25; 278(30):27988-96. PubMed ID: 12695516
    [Abstract] [Full Text] [Related]

  • 36. Nuclear Y-box-binding protein-1 is a poor prognostic marker and related to epidermal growth factor receptor in uterine cervical cancer.
    Nishio S, Ushijima K, Yamaguchi T, Sasajima Y, Tsuda H, Kasamatsu T, Kage M, Ono M, Kuwano M, Kamura T.
    Gynecol Oncol; 2014 Mar 25; 132(3):703-8. PubMed ID: 24486603
    [Abstract] [Full Text] [Related]

  • 37. Cluster analysis of p-glycoprotein, c-erb-B2 and P53 in relation to tumor histology strongly indicates prognosis in patients with operable non-small cell lung cancer.
    Bozcuk H, Gumus A, Ozbilim G, Sarper A, Kucukosmanoglu I, Ozbudak IH, Artac M, Ozdogan M, Samur M, Kaya A, Savas B.
    Med Sci Monit; 2005 Jun 25; 11(6):HY11-20. PubMed ID: 15917726
    [Abstract] [Full Text] [Related]

  • 38. p53 protein in non-small cell lung cancer as quantitated by enzyme-linked immunosorbent assay: relation to prognosis.
    Pappot H, Francis D, Brünner N, Grondahl-Hansen J, Osterlind K.
    Clin Cancer Res; 1996 Jan 25; 2(1):155-60. PubMed ID: 9816102
    [Abstract] [Full Text] [Related]

  • 39. Prognostic significance of nuclear or cytoplasmic nucleolin expression in human non-small cell lung cancer and its relationship with DNA-PKcs.
    Xu JY, Lu S, Xu XY, Hu SL, Li B, Li WX, Chang JY.
    Tumour Biol; 2016 Aug 25; 37(8):10349-56. PubMed ID: 26846099
    [Abstract] [Full Text] [Related]

  • 40. Expression of nuclear factor-kappaB and its clinical significance in nonsmall-cell lung cancer.
    Zhang Z, Ma J, Li N, Sun N, Wang C.
    Ann Thorac Surg; 2006 Jul 25; 82(1):243-8. PubMed ID: 16798222
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.